14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ABIO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for ARCA biopharma
(Updated on Apr 25, 2024)

Buy or Hold candidate since Mar 18, 2024 Gain 102.33% PDF

The ARCA biopharma stock price fell by -4.13% on the last day (Thursday, 25th Apr 2024) from $3.63 to $3.48. During the last trading day the stock fluctuated 7.03% from a day low at $3.41 to a day high of $3.65. The price has been going up and down for this period, and there has been a 7.08% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -44 thousand shares and in total, 54 thousand shares were bought and sold for approximately $187.35 thousand.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $3.71 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 113.80% during the next 3 months and, with a 90% probability hold a price between $4.81 and $7.94 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ABIO Signals & Forecast

The ARCA biopharma stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.44 and $2.47. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 23, 2024, and so far it has fallen -4.66%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The stock had a Golden Star Signal on Friday, September 15, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Friday, September 15, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for ARCA biopharma stock

ARCA biopharma finds support from accumulated volume at $3.40 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.240 between high and low, or 7.03%. For the last week the stock has had daily average volatility of 6.29%.

Our recommended stop-loss: $3.29 (-5.34%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (ABIO) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect ARCA biopharma to open at $3.51, and during the day (based on 14 day Average True Range), to move between $3.28 and $3.68, which gives a possible trading interval of +/-$0.204 (+/-5.85%) up or down from last closing price. If ARCA biopharma takes out the full calculated possible swing range there will be an estimated 11.70% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.40 (2.30%) than the resistance at $3.63 (4.31%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ARCA biopharma stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for ARCA biopharma stock to perform well in the short-term.

Current score: 2.864 Buy Candidate Unchanged

Predicted Opening Price for ARCA biopharma of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$3.51 ( 0.96%) $3.48

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ABIO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.75 7.85 %
R2 3.66 5.22 %
R1 3.61 3.59 %
Current price: 3.48
Support S1 3.42 -1.67 %
S2 3.37 -3.30 %
S3 3.27 -5.93 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 3.65 4.89 %
R1 3.63 4.31 %
Current price 3.48
Support S1 3.40 -2.30%
S2 3.25 -6.61%
S3 3.08 -11.49%

FAQ

What is the symbol for ARCA biopharma Stock and on which exchange is it traded?
The symbol for ARCA biopharma is ABIO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ARCA biopharma Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for ARCA biopharma stock to perform well in the short-term.

How to buy ARCA biopharma Stock?
ARCA biopharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ARCA biopharma Stock.

What's the current price of ARCA biopharma Stock?
As of the end of day on the Apr 25, 2024, the price of an ARCA biopharma (ABIO) share was $3.48.

What is the 52-week high and low for ARCA biopharma Stock?
The 52-week high for ARCA biopharma Stock is $3.88 and the 52-week low is $1.56.

What is the market capitalization of ARCA biopharma Stock?
As of the Apr 25, 2024, the market capitalization of ARCA biopharma is 50.464M.

When is the next earnings date for ARCA biopharma?
The upcoming earnings date for ARCA biopharma is Jul 19, 2024.
Click to get the best stock tips daily for free!

About ARCA biopharma

ARCA biopharma ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase... ABIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT